aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
InfraScan, founded in Philadelphia, develops and markets handheld infrared imaging systems designed for the detection of hematomas and brain bleeding in head trauma patients. Their core mission is to provide rapid, non-invasive diagnostic tools to improve outcomes in emergency and military medical settings. InfraScan's flagship product, the FDA-cleared Infrascanner, is used globally in various applications, including neuro-ICU teams and military battalion aid stations.
Notable individuals affiliated with InfraScan include a distinguished management team and a scientific advisory board composed of experts in medical imaging and neurology. The company has achieved significant milestones, such as the deployment of over 200 Infrascanners to U.S. Marine Corps battalion aid stations. InfraScan's impact is evident in its contribution to enhancing trauma care and potentially saving lives through early detection of brain injuries.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices
Technology
Infrared Imaging
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was InfraScan founded?
InfraScan was founded in 2004.
Where is InfraScan’s headquarters located?
InfraScan’s headquarters is located in Philadelphia, PA, US.
How many employees does InfraScan have?
InfraScan has 9 employees as of Feb 4, 2024.
How much has InfraScan raised to-date?
As of July 05, 2023, InfraScan has raised a total of $500k (USD) since Mar 24, 2014.
Add Comparison
Total Raised to Date
$500k
USD
Last Update Mar 24, 2014
Total Employees Over Time
9
As of Feb 2024
InfraScan Address
4800 South 13th Street
Bldg 1
Philadelphia,
Pennsylvania
19112
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts